Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Den nåværende markedsprisen på Merck & Co Inc er 1 396,63 kr, med et 24-timers handelsvolum på 8,83B kr. Eiendelens markedsverdi er 3,44T kr, etter en endring på 2.26% det siste døgnet.
Tokenisert Merck & Co Inc handles til 1 378,16 kr, med en tokenisert markedsverdi på 2,63M kr og et 24-timers handelsvolum på 1,27M kr. Den tokeniserte eiendelen har beveget seg 1.03% i løpet av de siste 24 timene.